跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Avisaph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Avisaph
Approved
STANDARD
Avisaph
Enicar Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a275d7d6f1337ac5
Company
Enicar Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
a275d7d6f1337ac5
Drug Approval Philippines Name
Avisaph
Product Name
Avisaph
Registration Number
DRP-12184
Brand Name
Avisaph
Generic Name
Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate
Dosage Form
Oral Suspension
Dosage Strength
500 mg/ 213 mg/ 325 mg per 10 mL
Manufacturer
Enicar Pharmaceuticals Pvt. Ltd.
Importer
Ollen Pharma Trading Inc.
Distributor
Ollen Pharma Trading Inc.
Issuance Date
27 June 2022
Expiry Date
21 June 2027
Pharmacologic Category
Antacid
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a275d7d6f1337ac5
Type
Standard
Back to Philippines FDA Approvals